GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Ordspono® | REGN-1979 | REGN1979
odronextamab is an approved drug (EMA (2024))
Compound class:
Antibody
Comment: Odronextamab (REGN1979) is a fully human CD3ε/CD20 bispecific IgG4-based antibody that redirects CD3+ cytotoxic T cells to selectively destroy CD20+ve malignant B cells [3]. Fc-mediated effector function has been minimised by modification of the IgG4 Fc domain.
|
Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes. EU EMA (2024) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11035 | odronextamab |
Synonyms ![]() |
| Ordspono® | REGN-1979 | REGN1979 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 962 |
| Other databases | |
| GtoPdb PubChem SID | 483123238 |
| Search PubMed clinical trials | odronextamab |
| Search PubMed titles | odronextamab |
| Search PubMed titles/abstracts | odronextamab |